Prenatal management with digoxin and sotalol combination for fetal supraventricular tachycardia: case report and review of literature.
Sustained fetal supraventricular tachycardia (SVT) with a heart rate of approximately 210 bpm may lead to increased atrial and venous pressures and congestive heart failure. There is no clear consensus regarding the best drug-treatment regimens for fetal SVT. However, considerable nonrandomized experience in the transmaternal treatment of fetal SVT is available with a number of antiarrhythmic agents. We report a case of fetal supraventricular tachyarrhythmia with hydrops detected at 32 weeks that was managed with combination of oral digoxin and sotalol and review management guidelines available in the literature.
Suri
Vanita
V
Department of Obstetrics and Gynecology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. dr_vanita_suri@yahoo.co.in
Keepanaseril
Anish
A
Aggarwal
Neelam
N
Vijayvergiya
Rajesh
R
D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D004077:Digoxin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D015160:Hydrops Fetalis / Q000188:drug therapy; D007231:Infant, Newborn; D011247:Pregnancy; D011295:Prenatal Care; D013015:Sotalol / Q000627:therapeutic use*; D013565:Sympatholytics / Q000627:therapeutic use*; D013617:Tachycardia, Supraventricular / Q000188:drug therapy*
D000889:Anti-Arrhythmia Agents; D013565:Sympatholytics; D004077:Digoxin; D013015:Sotalol